Osler's Disease

This is a condition that causes small, visible blood vessels to grow on the skin and inside the nose. It often leads to nosebleeds and sometimes bleeding in the stomach or intestines. It's a genetic condition, meaning it runs in families.

ConditionRare Disease

What people with Osler's Disease report

Every report comes from a Lived member, sent anonymously.

Have you tried Avastin (Bevacizumab) for Osler's Disease?

NameHow it went

About Osler's Disease

What It Is

Osler's disease, more often called hereditary hemorrhagic telangiectasia (HHT), is an inherited condition in which some blood vessels form incorrectly. Normally, blood flows from arteries through a network of tiny capillaries before it reaches the veins. In HHT, some arteries connect directly to veins instead. These faulty connections are fragile and carry blood at a higher pressure than they can easily handle, so they bleed easily. Small versions, called telangiectases, show up as tiny red spots on the lips, tongue, face and fingers, and also form inside the nose and the gut. Frequent, spontaneous nosebleeds are the most common sign and usually begin in childhood or the teenage years. Larger connections, called arteriovenous malformations (AVMs), can develop in the lungs, brain, liver or spine. Many AVMs cause no symptoms for years, yet some can lead to stroke, serious bleeding or strain on the heart, which is why HHT care puts so much weight on finding them early. HHT affects roughly 1 in 5,000 people and often goes unrecognized, partly because nosebleeds are so common in the general population.

Causes & Risk Factors

HHT is caused by a change (variant) in one of several genes that help blood vessels develop properly, most often the ENG gene (HHT type 1) or the ACVRL1 gene (HHT type 2). It is inherited in an autosomal dominant pattern, meaning one altered copy of the gene is enough to cause it. Each child of a parent with HHT has a 50% chance of inheriting it, and the chance is the same for sons and daughters. Occasionally the variant arises new in someone with no family history. The gene involved shapes the likely pattern. Type 1 tends to cause symptoms earlier and more often involves AVMs in the lungs and brain, while type 2 more often affects the liver. A rarer form caused by the SMAD4 gene also brings a tendency to growths (polyps) in the intestines. Still, anyone with HHT can develop any of these problems, and severity varies widely, even within one family. Nothing a person does causes HHT. Individual nosebleeds, however, can be set off by dry air or by picking, bumping or blowing the nose hard.

How It's Diagnosed

Doctors often make the diagnosis from a recognized clinical pattern, known as the Curaçao criteria: repeated spontaneous nosebleeds, multiple telangiectases in typical places such as the lips, mouth and fingers, AVMs in internal organs, and a close relative with HHT. Having at least three of the four makes the diagnosis definite. Because signs appear gradually, a child of an affected parent may not meet these criteria yet. Genetic testing finds the responsible variant in nearly 90% of people who clearly have HHT. Once a family's variant is known, relatives, including children too young to show signs, can be tested for it directly, so screening can begin early for those who carry it. After diagnosis, the next step is looking for hidden AVMs, since many cause no symptoms until a complication occurs. For adults, this usually means a bubble echocardiogram, an ultrasound of the heart taken while salt water shaken into tiny bubbles is injected into a vein. If bubbles pass through the lungs into the left side of the heart, a lung AVM is likely, and a chest CT scan is the usual next step. A brain MRI looks for brain AVMs, and blood tests check for iron deficiency and anemia. Some centers also image the liver. Children are screened too, although experts differ on the best way to check younger children's lungs.

Treatment Options

There is no cure for HHT, but treatment can greatly reduce bleeding and prevent many of its most serious complications. Care works best when coordinated by a center experienced with HHT, where specialists in the nose, lungs, brain, liver and digestive tract work together. For nosebleeds, keeping the inside of the nose moist every day with saline spray or petroleum jelly, and avoiding picking, bumping or hard blowing, is the foundation. When that isn't enough, tranexamic acid, a pill that slows the breakdown of blood clots, reduced nosebleeds in clinical trials and helps about half of people who try it. An ear, nose and throat specialist can also seal bleeding vessels with a laser or other ablation methods. This usually works well, but the benefit often fades within months, so it may need repeating. Because blood loss is ongoing for many people, replacing iron is a central part of care. Iron tablets are enough for some, while others need iron infusions into a vein. Transfusions are a last resort when iron cannot keep the blood count up. Bleeding spots in the stomach or intestine can be treated during endoscopy (a camera passed through the mouth or rectum), though doctors use this sparingly. When bleeding stays severe despite these steps, specialists may use bevacizumab (Avastin), an intravenous medicine that blocks the growth of new blood vessels. It is used off-label for HHT and can raise blood counts substantially and cut the need for transfusions and iron infusions. The trade-offs are repeated infusions and regular checks of blood pressure and urine protein, plus a risk of blood clots and harm to a developing pregnancy. Pomalidomide, an oral medicine, reduced nosebleed severity in a 2024 trial but is not FDA-approved for HHT. Lung AVMs large enough to treat are usually closed with embolization, a catheter procedure, threaded through a vein in the groin, that places small coils or plugs in the artery feeding the AVM. Smaller ones are rechecked with imaging every several years. Anyone with a lung AVM, even a small one, should take antibiotics before dental work below the gum line, including routine cleanings, because bacteria can pass through the AVM and cause a brain abscess. Brain AVMs may be treated with surgery, embolization or focused radiation. Liver AVMs are usually treated only if they lead to heart or liver failure.

What to Expect

HHT is lifelong and tends to change with age. Nosebleeds often become more frequent over the years, and bleeding from the stomach and intestines usually appears from the 40s onward. That bleeding is often slow and unnoticed, showing up instead as tiredness, breathlessness or low iron on blood tests. For many people, managing nosebleeds and iron levels is the main day-to-day part of the condition, and it can noticeably affect quality of life. With screening and appropriate treatment, most people with HHT can expect a near-normal life span. Follow-up typically includes regular blood counts, imaging of treated lung AVMs about 6 to 12 months after embolization and every few years afterward, and, for children, a repeat brain MRI in late adolescence. Pregnancy needs planning. It increases blood volume and can enlarge lung AVMs, and serious complications have occurred mostly in women whose HHT was not known or screened. Ideally, lung AVMs are checked and treated before pregnancy, and the pregnancy is managed as higher risk by a team familiar with HHT.

When to Seek Help

See a doctor about an HHT evaluation if you have frequent nosebleeds without an obvious cause, red spots on your lips, tongue or fingers, or a parent, sibling or child with HHT. Children in an affected family should be screened even without symptoms. If you already have HHT, contact your care team if nosebleeds become more frequent or heavier or you feel more tired or short of breath with activity, since these can signal worsening anemia. Get emergency care for a nosebleed that does not stop after 20 minutes of firm pressure, coughing up more than a few teaspoons of blood, vomiting blood, new black or tarry stools or a lot of blood in the stool, or feeling faint from bleeding. Call 911 for signs of a stroke or bleeding in the brain, such as sudden weakness or numbness on one side, trouble speaking, a sudden severe headache or a seizure.

Questions to Ask Your Doctor

  1. 1.Which screening tests do I need for lung, brain and liver AVMs, and how often should they be repeated?
  2. 2.Should my children or other relatives have genetic testing, and when should their screening start?
  3. 3.What can we do to reduce my nosebleeds, and when would tranexamic acid, ablation or a medicine like bevacizumab make sense?
  4. 4.How will we monitor my iron levels and blood counts, and what should I do between checks?
  5. 5.What precautions do I need before dental work, surgery or a pregnancy?

Last reviewed • Oct 2026

Educational content, not medical advice.